Onxeo (EU: ONXEO)

Currency in EUR

Last close As at 06/02/2023

EUR0.33

−0.01 (−2.94%)

Market capitalisation

EUR37m

Latest Insights

View More

Healthcare

Onxeo – Edison Open House interview

Healthcare

Onxeo – executive interview

Healthcare

Onxeo — Expanding AsiDNA R&D programme

Sector

Healthcare

Balance Sheet

Forecast net debt (€m)

N/A

Forecast gearing ratio (%)

N/A

Share Price Performance

Price Performance
% 1M 3M 12M
Actual 1.7 (3.4) (41.5)
Relative (6.8) (6.6) (38.8)
52 week high/low €0.6/€0.3

Financials

Edison Investment Research is terminating coverage on Steakholder Foods (formerly known as MeaTech) (MITC), Mesoblast (MSB), Bluglass (BLG), InMed Pharmaceuticals (INM), Onxeo (ONXEO), Arcane Crypto (ARCANE) and Aberdeen Diversified Income and Growth Trust (ADIG). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Y/E Dec Revenue (€m) EBITDA (€m) PBT (€m) EPS (fd) (c) P/E (x) P/CF (x)
2019A 4.3 (9.1) (11.5) (14.98) N/A N/A
2020A 1.8 (7.2) (8.2) (12.26) N/A N/A
2021E N/A N/A N/A N/A N/A N/A
2022E N/A N/A N/A N/A N/A N/A

More from our Healthcare team

Healthcare

DNA damage repair inhibitors

Analyst of the week

Soo Romanoff

Soo Romanoff

Managing Director - Head of Content, Healthcare

Read latest

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free